With the recent progress in biotechnology and genetic engineering, a variety of proteins have formed a very important class of therapeutic agents. However, most proteins have short half-lives in vivo requiring multiple treatments to provide efficacy. In order to overcome this limitation, sustained release systems as hydrophilic microspheres and hydrophobic microcapsules have received extensive attention in recent years. As therapeutic proteins delivery systems, it is necessary to maintain protein bioactivity during microspheres or microcapsules formation as much as possible. This paper reviews different influencing factors that are closely involved in protein denaturation during the preparation of hydrophilic polymer microspheres and hydrophobic polymer microcapsules. The various strategies usually employed for overcoming these obstacles are described in detail. Both processing and formulation parameters can be modified for improving protein stability. The maximum or full protein stability retention within the microspheres or microcapsules might be achieved by individual or combined optimized strategies. In addition, the common techniques for proteins stability determination are also briefly reviewed.
INTRODUCTION
The advent of recombinant DNA technology has made possible the commercial production of proteins for pharmaceutical applications from the early 1980s [1] . These proteins generally display therapeutically favorable properties, such as higher target specificity and pharmacological potency when compared to traditional small molecule drugs [2] . Therefore, they become a very important class of therapeutic agents in recent years, for example, insulin used for diabetic patient, Tumor Necrosis Factor (TNF) and Interferon for cancer, and also vaccine and mono-antibodies for therapy. However, most protein drugs have short half-lives in vivo requiring multiple treatments to provide efficacy. Until now, most of therapeutic proteins are presently delivered by injections. In some cases, multiple injections in one day are necessary in order to maintain effective plasma concentration, which results in poor compliance of patients. At the same time, proteins are also unstable in biological fluids, can be easily digested by enzyme, and not fully absorbed from the gastrointestinal tract because of their relatively high molecular weights, which lead to low bioavailability in vivo.
In order to overcome above limitations, sustained release systems for therapeutic proteins have received extensive attention in recent years. These systems can not only effectively prevent degradation of proteins in the body，but also improve the stability and achieve sustained-release or controlled-release profile in vivo [3] [4] [5] . Until now, many delivery systems for proteins are developed, such as liposome, micelle, degradable polymer microspheres and microcapsules [6] [7] [8] [9] . Among them, polymer microspheres and microcapsules show great potentials in delivery of proteins, because they own many advantages as follows [10] [11] [12] [13] : (i) they can protect proteins against rapid degradation and clearance after administration; (ii) desired therapeutic effect over a long period of time can be achieved，while for traditional injections, the schematic illustration of drug levels in the blood rise after administration and then decrease until the next one as shown in (Fig. 1) ; (iii) suitable release *Address correspondence to this author at the National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, P. R. China; Tel:/Fax: 86-10-82544931; E-mail: wanglianyan@home.ipe.ac.cn § The authors have the same contributions profile could be obtained by designing the size and inner structure of microspheres and microcapsules; (iv) targeting molecules could be conjugated onto the surface of microspheres or microcapsules, and the proteins could be delivered into definite location. It is well known that proteins as large macromolecules consist of a sequence of amino acids and highly assemble into complex structures, which is closely related with their biologically active state and corresponding physiological functions [14, 15] . Chemical stability of proteins typically involves the integrity of the amino acid sequence (primary structure) and the reactivity of the side chains. As usual, the activity of proteins depends on the secondary, tertiary and even quaternary structures, which is crucial for the biological functions. Although encapsulation of biomacromolecules in microspheres or microcapsules is now a routine procedure in many laboratories for achieving controlled and targeted delivery strategies, there are many process parameters during encapsulation operations can affect the activity and stability of proteins [16] , which will lead to denaturation of proteins, and this will further result in therapeutic inactivity and unpredictable side effects, such as immunogenicity or toxicity [17] . Therefore, it is significantly 
Preparation Methods of Microspheres for Protein Delivery
Until now, there are many methods developed for preparation of hydrophilic polymer microspheres for protein delivery as shown in Table 2 , including emulsion cross-linking, coacervation/precipitation, spray-drying, ionic gelation and template-assembly method. For different methods, the encapsulated proteins must maintain specific, folded, three-dimensional structure (conformation) during encapsulation process. Loss of biological activity and change in immunogenicity as a result of protein aggregation or denaturation will result in serious side effects. It is the most important challenges to maintain the complexity of protein structure for delivery of biologically native one during encapsulation [38] . Studies showed that many manufacturing methods for microspheres can damage complex structures of proteins by exposing them to potentially damaging conditions, such as aqueous/organic interfaces, elevated temperatures, vigorous agitation, detergents and so on [14] . Therefore, the protein activity must be maintained for different preparation methods of microspheres. [21, 39] Coacervation/precipitation agglomeration [40] Spray-drying high temperature, shearing stress [1, 41] Ionic gelation polymer [42, 43] Template-assembly method polymer [44] 
Emulsion Cross-linking
Proteins could be entrapped into water soluble polymer microspheres like chitosan, collagen and gelatin by emulsification combined with cross-linking method. The detailed preparation process is shown as (Fig. 2) [45] . Protein is dissolved or dispersed into polymer solution as water phase (W), and then this solution is emulsified into oil phase (O) to form W/O emulsion by mechanical stirring, ultrasonication technique or homogenization. Finally, the cross-linker agent is dropped into the system to solidify the emulsion into microspheres. The environment of water phase such as pH values and additives will not only exert important influence on drug activity, but also have impact on microsphere formation, morphology and structure, which will further affect the encapsulation efficiency and release profile in vivo. Cross-linking process includes physical and chemical cross-linking methods. Physical crosslinking can usually maintain high activity of proteins, while the lower encapsulation efficiency and fast release can be obtained due to weak solidification for microspheres. However, the higher encapsulation efficiency and lower release profile can be achieved when the microspheres are solidified by chemical cross-linking agents. Therefore, the suitable water phase and cross-linking process should be chosen during preparation of protein loaded microspheres by W/O emulsion method. For example, Jose et al. employed this method to prepare chitosan microspheres containing insulin, and formulation parameters as chitosan concentration, glutaraldehyde concentration and cross-linking time were optimized to develop microspheres with suitable performance in vivo. The results revealed that there was a significant reduction in blood glucose level after administration of the optimized formulation, in comparison to a subcutaneous injection of insulin solution [46] . Sivakumar et al. also used the same technique to encapsulate hepatitis B surface antigen (HBsAg) into chitosan. It was found that the chitosan microspheres induced significantly higher immunoglobulin levels comparison with the conventional alum-adsorbed system [47] .
Although the protein could be successfully encapsulated into hydrophilic polymer microspheres, there still existed a few drawbacks. The proteins easily aggregate in the interface between water and oil phase during emulsifying process, which result in their activity reduction. Moreover, the intense shearing strength brought by a high-speed homogenizer or a sonicator also led to protein denaturation and aggregation. In addition, the cross-linking reactions will happen between proteins and/or between protein and polymer, leading to activity reduction of proteins. Furthermore, complete removal of the unreacted cross-linking agent may also be a big challenge.
Coacervation/Precipitation
This process consists of dispersing the proteins into solution of polymer and decreasing the solubility of the polymer by addition of a third component to the system [48] [49] [50] [51] . At a particular point, the process yields two phases (phase separation): the polymer containing coacervate phase and the supernatant phase depleted in polymer. The coacervation process includes the following three steps: (i) phase separation of the coating polymer solution, (ii) adsorption of the coacervate around the protein particles, and (iii) solidification of the microspheres.
The coacervation process is mainly used to encapsulate watersoluble proteins. Ozbas-Turan S. et al employed chitosan to encapsulate interleulin-2 by this process. They found that the addition rate of non-solvent (sodium sulfate) should match with slow extraction of chitosan, so that the chitosan has sufficient time to deposit and evenly coat on the protein particle surface during the coacervation process [40, 52] . Moreover, the concentration of the polymer is also very important, since too higher concentrations would result in rapid phase separation and non-uniform coating of the polymer on the protein particles. Due to absence of any emulsion stabilizer in the coacervation process, agglomeration is a common problem in this method [40] . The coacervate droplets are extremely sticky and adhere to each other before the complete phase separation or the hardening stages. Adjusting the stirring rate, temperature, or the addition of an additive is known to overcome this problem [40] . This process avoids the use of toxic organic solvents and crosslinking agent, which is favorable for activity retention of proteins.
Spray-drying
Spray drying is a well-established method commonly used in the pharmaceutical industry for producing a dry powder from a liquid phase. The method is based on drying of atomized droplets in a stream of hot air. In principle, hydrophilic polymer is dissolved in aqueous solution, and the drug is dispersed or dissolved in polymer solution. This solution or dispersion is then atomized in a stream of hot air that leads to the formation of small droplets, from which solvent instantaneously evaporates leading to the microspheres in typical size ranges from 1 to 100 <m depending on atomizing conditions. To date, many hydrophilic polymer microspheres loading proteins were successfully prepared by this method, such as chitosan, mannitol, hydroxypropyl methylcellulose and carbopol microspheres [53] [54] [55] [56] .
This technique shows some important advantages over other encapsulation techniques. The preparation process is rapid, convenient and easy to scale-up. Furthermore, this process is suitable for most of proteins because it doesn't depend on the solubility parameter of proteins. This process are easily to induce aggregation and denaturation of sensitive proteins due to thermal and shearing stresses, so stability of microencapsulated proteins during preparation becomes a major concern.
Ionic Gelation
In recent year, the method of ionic gelation for preparation of hydrophilic polymer microspheres containing proteins has attracted much attention because the process is very simple and mild, which is helpful to retain bioactivity of loaded proteins. In this method, the reversible physical cross-linking by electrostatic interaction is employed for microspheres formation. In detail, proteins are premixed with hydrophilic polymer solution, which is then dropped into ionic solution under constant stirring. Bodmeier et al. reported that the tripolyphosphate (TPP) -chitosan microspheres were obtained by dropping chitosan solution containing proteins into a TPP solution [27] , and many researchers have explored its potential for pharmaceutical usage [42, 43, 57] . The gelation of alginate can also be carried out under an extremely mild environment. Alginate microspheres can be prepared by extruding a solution of sodium alginate containing proteins as droplets into a divalent cross-linking solution such as Ca . The native activity of loaded proteins by this method could be well retained.
Template-assembly Method
In this process, a suitable template should be chosen at first, and then protein drugs were adsorbed on the surface of template microparticles, and next the polyelectrolyte were assembled on the core template by layer-by-layer technology, and finally the template was removed by certain method [44, 58] . The activity of proteins could be highly maintained due to the mild preparation conditions, and the whole process was conducted in aqueous phase avoiding oil-water interface and intense shear force.
Factors Influencing Protein Stability
The protein can be dissolved in the hydrophilic polymer solution and be further entrapped in the microspheres. Until now, it is identified that there are some process parameters to affect protein stability during preparation, including water-oil interface, intense shearing stress, high temperature and harsh cross-linking reaction. The factors influencing protein stability vary in preparation methods and processes.
The water-oil interface is a well-known factor to cause denaturation of proteins. As a usual, proteins become especially prone to migrate and adsorb at the interface to form aggregation. They undergo unfolding by presenting their hydrophobic area to the organic solvent, and this area is usually buried in the molecular structure when protein in active state [1] . This influence is often happened in the emulsion cross-linking method, and the formation of w/o emulsion is mainly responsible for protein denaturation. Protein degradation might also take place upon mechanical shearing and exposure to ultrasound due to intense shearing force. For ultrasound emulsification technique, there is a serious drawback that ultrasound cavitation could create drastic conditions inside the medium for an extremely short time. According to the hot spot theory, high temperatures and high pressures inside the collapsing cavitation bubbles could be produced during ultrasound emulsification [59, 60] . Moreover, there exist strong physical forces as shearing forces, disturbance force and shock waves during broken of droplets [61] . This inertial cavitation also induces the formation of free radical via the thermal dissociation of water [62] . Under these extreme physical conditions, sonication could cause the breakdown of the hydrogen bonding and Van der Waals interactions in the polypeptide chains, leading to change of the secondary and tertiary structure of the protein [63] . The bioactivities were lost with the alteration of protein secondary and tertiary structure. It is also considerable that shearing augments the chances of soluble proteins adsorption onto air/water and water/oil interfaces [1] , which further promotes hydrophobic interactions between proteins and interface leading to aggregation.
High temperature is also an important parameter affecting protein stability. During the temperature-induced denaturing transition, a protein changes from a rather well-organized structure into a random coil-like structure, which results in the contact between hydrophobic amino acids and water [64] . For spay drying, one of the major issues is the maintenance of protein activity during the process of high temperature.
In emulsion cross-linking method, the use of harsh crosslinking agents might possibly induce chemical reactions between the active proteins and/or between proteins and polymers, which will also lead to denaturation of proteins. For example, chitosan microspheres are solidified by reaction between primary amine groups of chitosan and aldehyde group of glutaraldehyde. And this reaction could be also occurred between proteins and glutaraldehyde due to abundant of primary amine groups in proteins, which finally induce the denaturation of proteins.
Sometimes, the polymers may also affect proteins stability by themselves due to the interaction between polymers and the proteins in the solid formulation. For example, Yang et al. prepared chitosan-based microspheres containing protein of salmon calcitonin (sCT) by spray drying process using mannitol as cryoprotecting agent [22] , and the effect of chitosan on the physicochemical stability of the protein was investigated. The results demonstrated that addition of chitosan decreased the recovery of sCT from the spray-dried powders, because the interaction between chitosan and sCT was strengthened by dehydration during the spray-drying, and this further led to some irreversible complex formation. It was found that chitosan had slight effect on secondary structure of sCT in an aqueous formulation, but it was not detrimental to chemical integrity of sCT.
In summary, there are many parameters and conditions to affect protein stability during microspheres preparation. In order to realize successful encapsulation of active macromolecules as proteins into hydrophilic polymer microspheres, the above factors influencing protein stability must be considered.
Strategies for Improving Protein Stability During Microencapsulation
As therapeutic proteins delivery systems, it is necessary to maintain protein bioactivity during microspheres formation as much as possible. In order to achieve this aim, many strategies are developed in recent years, which will be elaborated in detail as follows.
Additives
For stabilization of proteins, the use of additives during the encapsulation process is the most widely used and common strategy. Until now, many additives were attempted and developed, such as sugars, amino acids, amines, glycerol and so on. These additives can increase stability of proteins through various mechanisms. The protective effect can be mediated by the formation of new hydrogen bonds and polar interactions at the surface of the protein, which can increase the free energy of protein denaturation and changes in water [65] . On the other hand, proteins can be stabilized by electrostatic interactions between the additive substance and protein because the tertiary structure of protein can be well maintained by charged macromolecules [66] .
For example, Chou et al. prepared biocompatible microparticles for intranasal protein delivery by lyophilization [67] . Hydroxypropyl--cyclodextrin (HP--CD) and d-alpha-tocopheryl poly (ethylene glycol 1000) succinate (TPGS 1000) were used as additives. The results showed that the activity of lysozyme was well preserved by HP--CD during the preparation process [68] . The stabilizing effect of HP--CD is contributed by the fact that the aromatic phenylalanine, tyrosine and tryptophan residues in proteins could incorporate in the hydrophobic internal cavity of CD [69] . Wang et al. prepared chitsoan microspheres for encapsulation of insulin by emulsion cross-linking method. Different additives were added into the aqueous phase to improve stability of insulin. It was shown that gelatin could greatly improve insulin stability. The possible reason is that chemical reaction between amine groups of gelatin and the cross-linker protect insulin against chemical modification during the preparation process [20] .
Optimization of Microsphere Formation
Although microspheres can be obtained by emulsification/solidification technique, the emulsion is usually prepared by high-energy instruments or methods with intense shearing force, which may result in loss of protein activity. To overcome this disadvantage, the membrane emulsification technique was applied to prepare hydrophilic microspheres with narrow size distribution. This technique could improve protein activity due to mild emulsification without intense shearing force [20, 21] .
Another useful method for avoiding the denaturation of protein is to modify or optimize solidification process of microspheres. For example, in order to reduce chemical reaction between insulin and cross-linking agent of glutaraldehyde and improve the encapsulated insulin activity during solidification, Wang et al. employed a stepwise cross-linking method to greatly improve the stability of protein [20] . First, a w/o emulsion of chitosan/insulin in paraffin/petroleum ether mixture was prepared, and then TPP was added as an ionic cross-linker to form gel network structure, and finally glutaraldehyde was introduce for further solidification of microspheres as shown in (Fig. 3) . In this method, the gel network could effectively inhibit the interaction between insulin and glutaraldehyde, so the native insulin was maintained in maximum extent as shown in (Fig.  4d) .
In addition, the stability of encapsulated protein could be also improved by different loading ways. For example, Wang et al. compared the integrity of loaded insulin between adsorption and direct encapsulation [21] . As shown in (Fig. 4) , no loss of insulin activity was found in the case of adsorption method (Fig. 4b) , while serious activity loss was found in direct encapsulation method due to reaction between insulin and cross-linker of glutaraldehyde (Fig.  4c) . Zhang et al. prepared uniform-sized alginate-chitosan microspheres and employed three ways for insulin loading as shown in (Fig. 5) [25] . It was found that the remarkable activity maintenance (99.4%) was obtained when the insulin was loaded during the chitosan solidification process (Method B) as shown in (Fig. 6) . In case of activity retention, the denaturation of the insulin in Method A (insulin was loaded during the first solidification liquid) was probably caused by the ultrasonic oscillation during the preparation of mini-emulsion. While Method B is a mild process and could effectively maintain the activity of insulin. Method C was the combination of Method A and Method B, so the loading efficiency and activity retention decreased. 
Modification of Hydrophilic Polymers
To prevent the instability of protein during encapsulation, which induced by the interaction between polymers and the proteins, an effective strategy of modification for hydrophilic polymers has been developed. Chitosan is only soluble in its protonated form in acidic environments, which may affect stability of protein. In order to overcome this adverse environment, different derivatives were developed for protein delivery. For example, Li et al. modified chitosan into glycol chitosan-5 -cholanic acid conjugates (HGC) as a novel protein delivery system. It was found that the biological activities of encapsulated Noggin are not impaired by encapsulation in the HGC carrier compared with chitosan [70] . In addition, N-trimethyl chitosan chloride (TMC) was also employed for microspheres formation as protein delivery, which could provide maximum stability of the protein due to its good water solubility over a wide pH range [71, 72] .
MICROCAPSULES BASED HYDROPHOBIC POLYMERS 3.1. Type of Polymers for Protein Delivery
The prerequisites for polymers used as proteins delivery systems include biocompatibility, controllable biodegradability, absorbability, low toxicity of the degradation products, and controlled and sustained release potential [73] . Microcapsules based hydrophobic polymers have been prepared from polyesters such as poly(d, l-lactide-co-glycolide) (PLGA), poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and monomethoxypoly(ethylene glycol)-b-poly-d,l-lactide (PELA), polyanhydrides as 1,6-bis(pcarboxyphenoxy) hexane (CPH), poly(1,8-bis(p-carboxyphenoxy)-3,6-dioxa-octane) (poly(CPTEG)), and poly 1,3-bis-(p-carboxyphenoxy) propane-co-sebacic acid (p(CPP:SA)) copolymer, and poly(orthoesters) [10, [74] [75] [76] .
Among these polymers, PLGA has been most extensively investigated for proteins delivery, owing to its advantages such as biocompatibility, non-toxic degradation products, approval by US Food and Drug Administration (FDA), well-defined protein encap- sulation and long-acting profiles [77] . The drawback of PLGA for protein delivery is its deleterious effect on protein stability and activity. PLGA is a bulk-eroding polymer, so protein encapsulated in PLGA carriers is exposed to elevated moisture environment which may cause aggregation of proteins [75, 78, 79] . Another issue is that some proteins may become denatured and/or irreversibly aggregated in the acid microenvironment (pH 2-3) caused by PLGA degradation products [74, 78, 79] . Polyanhydrides have also been investigated for proteins delivery application. Their surface erosion characteristics dedicates the superiority with near zero-order release rate, and the protein stability is also improved by minimizing water interaction with drug prior to release [74, 75, 78] . The microenvironmental pH resulting from polyanhyride degradation is higher than that caused by PLGA, which is less detrimental to biologically active proteins [74, 79] . What's more, the degradation rates of polyanhydrides can be easily tailored by adjusting the polymer chemistry [74, 75, 78] .
Preparation Methods of Microcapsules for Protein Delivery
Various techniques have been utilized to fabricate hydrophobic polymer microcapsules, including hot melt, emulsification-solvent removal, spray drying, organic phase separation, cryogenic atomization, supercritical fluid and so on [4, 10, 74, 76, 78] . The common methods for proteins encapsulation are summarized in Table 3 . Organic phase separation agglomeration [18, 48] 
Emulsification-solvent Removal Method
For the hydrophobic microcapsules as proteins delivery system, the method of emulsification-solvent removal technique has been widely used and extensively investigated. The emulsions can be prepared by emulsifying a concentrated aqueous solution of protein or the freeze-dried solid in organic solvent, followed by secondary emulsification in aqueous continuous phase or dispersing the emulsion into another oil phase. The former is called water-in-oil-inwater double emulsion (W/O/W) as shown in (Fig. 7) (1), and the latter is solid-in-oil-in-water emulsion (S/O/W) [3, 10, 74, 77, [80] [81] [82] [83] [84] [85] [86] [87] . When W/O/W method was employed, the water-oil interface between internal aqueous phase and organic phase in the formation of the primary emulsions, was regarded as the major cause for protein instability during proteins microencapsulation [83, 88, 89] . To overcome this limitation, a primary emulsion-free method, solid-inoil-in-water emulsion (S/O/W), was developed [3, 82, 84, 85, 90, 91] , which could effectively maintain protein stability due to thoroughly avoiding the presence of water-oil interface in the whole process [73, 74] . In addition, some excipients as poly(ethylene glycol) (PEG), dextran, and cetyltrimethylammonium bromide (CTAB), water-soluble proteins were also employed for keeping protein activity retention [3, 82, 84, 85, 90, 91] .
The organic solvents most frequently used in this technique are methylene chloride and ethyl acetate. The solvent removal technique may be divided into solvent-evaporation and solventextraction according to different characteristics of solvents [10] . Solvent-evaporation method was usually chosen for solidification of microcapsules when methylene chloride as solvent due to its low melting point [10, 75, 92] , and the solvent could be removed through evaporation at atmosphere or at a reduced pressure [10, 93, 94] . In some literatures, methylene chloride could also be removed by solvent-extraction method using aqueous solution containing 6% isopropanol [10, 95] . The microcapsules could be solidified by solvent-extraction method when ethyl acetate as solvent due to its high solubility in water (8.7%, w/v) [10, 96] . In detail, the water-inoil-in-water double emulsion was poured into a large volume of aqueous solution, and the solvent of ethyl acetate was extracted to allow the solidification of microcapsules [10, 96] .
Spray Drying Method
Spray drying is an attractive and relatively simple method to prepare hydrophobic polymer microcapsules for protein delivery [18] . As shown in (Fig. 7) (2), W/O emulsion is atomized in a flow of drying air at higher temperature, and microcapsules are collected with rapid vaporization of organic solvent [18] . This method is not suitable for encapsulation of thermally sensitive proteins due to the application of high temperature during preparation process. In order to overcome this limitation, the novel spraying method with lowtemperature was reported by several groups [18] . For example, Lopac et al. had fabricated polyanhydride-based microspheres using solid-in-oil-in-oil double emulsion combined with cryogenic atomization [74] . In detail, the polymer and lyophilized OVA dissolved in methylene chloride were pumped into ethanol which was cooled by liquid nitrogen. The mixture was then atomized by an ultrasonic atomizing nozzle, which was placed in a 80 freezer for three days to further remove liquid nitrogen, ethanol, and methylene chloride, and finally the microcapsules were collected and dried. The results indicated that protein released from polyanhydride-based microcapsules remained integral structure.
There are many advantages for spray drying including rapidity, convenience, ease to scale-up, mild preparation conditions, less dependence on the solubility parameter of drug and the polymer [48] .
Organic Phase Separation Method
Organic phase separation is also called coacervation. As shown in (Fig. 7) (3) , microcapsules fabrication using this technique consists of two steps: (i) phase separation induced by adding an organic non-solvent for polymer and protein to water-in-oil (W/O) emulsion; (ii) solidification of the microcapsules by transferring the twophase system into a large volume of an organic hardening agent miscible only with the polymer solvent and non-solvent [18, 48] .
The drawbacks of organic phase separation method include tendency to produce agglomerated particles, difficulty in mass production, requirement of large quantities of organic solvent, and difficulty to remove residual solvents from the final microsphere product [48] .
Factors Influencing Protein Stability
Although hydrophobic polymer microcapsules containing proteins could be successfully prepared by above methods, which could also solve the limitation of therapeutic proteins in some degree such as poor stability, low bioavailability, short in vivo halflives, the microencapsulation process may lead to protein instability including denaturation, aggregation, unfolding, deamidation [17, 73, 88, 89] . The factors resulting in protein instability include water-oil interface [3, 17, 73, 75, 80, 81, 88, 93, 97, 98] , shear forces [10, 17, 73, 88] , heat [3, 73] and so on.
During the microcapsules preparation process by W/O/W, the water-oil interface has been regarded as the major reason for protein instability [83, 88, 89] . During formation of primary emulsion of water in oil by sonication or homogenization, there appear interface with large area. Protein may adsorb at the interface, unfold, and subsequently aggregate, resulting in inactivation and denatura-tion [3, 17, 73, 75, 80, 81, 83, 88, 89, 97, 98] . When protein accumulates at the interface, they may interact with hydrophobic polymers, which further leads to protein instability [74, 97] . During preparation of double emulsion of water-in-oil-in-water, the formation of oil-water interface may also destroy protein stability.
Cavitation stress or heat production provoked by homogenization or ultrasonification during primary and double emulsion formation will also result in activity loss of proteins [73] . Moreover, physical stresses or heat during spray-drying or spray-freeze-drying are also crucial factors leading to protein instability [3, 73] .
In addition, accumulation of acidic monomers and subsequent generation of acidic microenvironment inside microcapsules with degradation of hydrophobic polymers would also result in protein instability [74, 78, 80, 81, 98, 99] . Furthermore, moisture in bulkeroding polymer-based microcapsules is elevated during protein release due to the degradation of polymers, which will lead to denaturation of proteins [17, 81, [98] [99] [100] .
Strategies for Improving Stability of Proteins
Microencapsulation processes usually involve harsh conditions leading to protein instability and denaturation as mentioned in above section. Denatured proteins will further result in therapeutic inactivity and unpredictable side effects, such as immunogenicity or toxicity [101] . Therefore, it is significantly important that the stability and activity of proteins must be retained during encapsulation process. With the development of protein encapsulation, many attempts are made for improvement of protein stability, which would be elaborated in details as follows.
Stabilizer
To prevent protein aggregation in water-oil interface during microcapsule formation, the addition of stabilizer into the systems is well developed strategies. Until now, there are various stabilizers to be verified useful for improving protein stability, including polyvinyl alcohol (PVA), amino acids, proteins, sugars, surfactants and inorganic salts [97, [102] [103] [104] [105] .
Stabilizer could play the function of stabilizing proteins by various ways. Firstly, the stabilizer could effectively maintain protein stability via competitive adsorption on the oil-water interface. He et al. employed PVA as a stabilizer to prepare the PLGA microcapsules loaded protein of staphylokinase variant K35R (DGR) [106] . It was found that the aggregation of DGR could be effectively inhibited by addition of PVA into inner water phase, and the active DGR recovery reached to more than 90%, while approximately 84% DGR aggregation was found in control (without PVA). Secondly, some stabilizer could protect proteins stability by forming a hydration layer. Jeffrey et al. prepared PLGA microcapsules loaded recombinant human growth hormone (rhGH) or recombinant human interferon-(rhIFN-) by emulsion solvent evaporation method, using Tween 20, Tween 80, trehalose and mannitol to stabilize encapsulated proteins [107] . The results showed that sugars of trehalose and mannitol demonstrated much better stabilizing effect on proteins comparison with surfactants of Tween 20 and Tween 80. Thirdly, the formation of polyelectrolyte complex between therapeutic protein and polymer could also maintain protein stability during encapsulation. Chondroitin sulfate (CsA) is an acidic mucopolysaccharide, which is able to form ionic complexes with positively charged proteins. CsA was used as a polymeric additive to form the ionic complex with insulin (InS) [108] , and then this complex was encapsulated into PLGA microcapsules by emulsion-solvent evaporation technique. The results of reverse phase high-performance liquid chromatography (RP-HPLC) demonstrated that the retention time of insulin in complex was almost identical to native protein comparison with free insulin as shown in (Fig. 8) .
Ajay et al. synthesized a poly-(ethylene glycol)-b-poly(Lhistidine) diblock copolymer (PEG-polyHis) and then incubated with insulin to form protein-PGE-polyHis complex. This complex greatly reduced aggregation of insulin during exposing water-oil interface [109] . Ionic interactions between insulin and PEG-polyHis could prevent contacts of insulin with the oil phase as shown in (Fig. 9) . 
Increase of Protein Concentrations
Studies have demonstrated that interfacial denaturation of proteins closely associates with their concentrations [18, 110] . The protein amounts for adsorption and denaturation at the water-oil interface are always considered to be fixed. As usual, the proportion of irrecoverable protein may be especially high in case of low amounts of proteins. From this point of view, increasing the protein concentrations is another useful strategy for improving protein stability. Sah et al. prepared PLGA microcapsules loaded ribonuclease A (RNase) by emulsion-solvent evaporation using different RNase concentrations from 0.2 to 1.5 mg/mL, and the results exhibited that the active proportion of recoverable protein increased from 78% to 93% with increase of protein concentrations [111] . Similar results also obtained in encapsulation of human growth hormone (rhGH) into PLGA microcapsules, and the recoverable soluble monomer of rhGH increased from 53% to 86% with its concentrations raising from 10 to 100 mg/mL. Therefore, the increase of protein concentrations is favorable for improvement of its stability.
Modification of Proteins
The third attractive strategy for improving proteins stability during encapsulation is modification of proteins. The proteins could be modified by physical or chemical method. In the method of physical modification, the protein and modifier was co-lyophilized to form microparticles, which further encapsulated into PLGA microcapsules. For example, He mixed recombinant human erythropoietin (rhEPO) with serum albumin (HSA) to fabricate microparticles, and then further encapsulated into PLGA microcapsules [112] . The results of integrity measurement for rhEPO showed that the native structure of protein was successfully maintained during the encapsulation process. The co-lyophilization of -chymotrypsin and poly (ethylene-glycol) (PEG) also greatly reduced aggregation of proteins in interface [113] . In the method of chemical modification, the protein is chemically conjugated with PEG, and then further encapsulated into hydrophobic microcapsules. In general, PEGylation of proteins could improves stability due to prevention protein from adsorbing on water-oil interface [114] . Ingrid et al. prepared methoxy polyethylene glycol (mPEG, MW 5000) conjugation of lysozyme, and further encapsulated into PLGA microcasules by W/O/W process [113] . The results demonstrated that Pegylated lysozyme exhibited much better stability than native lysozyme during exposure to organic solvent (dichloromethane) and homogenization. Manish et al. prepared mPEG conjugated IFN-and then encapsulated it into PLGA microcapsules [115] . Most of the pegylated proteins maintained their native structure during exposure to harsh microencapsulation process.
Modification of Polymers
The modification of hydrophobic polymers such as PLA and PLGA with either hydrophilic or hydrophobic segments is another potential strategy for improving protein stability during encapsulation. The modified polymer could effectively reduce protein adsorption on water-oil interface, which further decreases the aggregation of proteins. For example, Bouillot et al. synthesized a PLA-PEG-PLA tri-blocks co-polymer, which was employed to encapsulate BSA by double-emulsion method [116] . Results suggested that protein adsorption and denaturation had been minimized through introducing hydrophilic PEG into PLA chains. Wan et al. obtained block polymer of POE-PEG-POE by conjugating PEG with hydrophilic Poly (ortho esters) (POE), which was further used to encapsulate BSA [117] . It was demonstrated that the protein integrity was well maintained for up to 8 weeks, which suggested that the conjugation of PEG could well protect protein activity.
Modification of Preparation Process
A charming strategy for avoiding the denaturation of protein is to modify or optimize preparation process of microcapsules. In order to prevent the protein adsorption on water/oil interface, the solid protein was directly dispersed into oil phase containing polymer, and then further encapsulated into microcapsules by suitable process. For example, Yuan et al. developed a novel multiemulsion method of S/O 1 /O 2 /W for protein encapsulation [118] . The model proteins of Horse myoglobin and Bovine serum albumin were encapsulated in the dextran glassy microparticles, which were further dispersed in the PLGA oil phase. The use of dextran glassy microparticles could effectively stabilize proteins in the PLGA matrix. Ingrid et al. also employed S/O/W method to stabilize encapsulated protein of -chymotrypsin. In these processes, protein conformational mobility is reduced due to the absence of water, which is significantly favorable for maintaining stability of proteins during encapsulation [113] . Lee et al. compared the stability of encapsulated lysozyme by conventional W/O/W and S/O/W methods [119] . The results demonstrated that the method of S/O/W offered an effective strategy to preserve stability and bioactivity of the encapsulated proteins.
Mitigation of Acidic Environment
The acid environment could be produced during degradation of PLGA microcapsules, which had significant influence on protein stability and activity [120] . The acidic microenvironment could be improved by adding basic additives during microcapsule preparation. For example, Zhu et al. prepared PLGA microcapsule contain- [121] . The basic additive of Mg(OH) 2 was added into inner water phase for neutralization of acid. The results exhibited that the BSA structural loss and aggregation was inhibited for over one month. Anne et al. also coencapsulated Mg(OH) 2 into PLGA microcapsule to improve the stability of lysozyme, which demonstrated better lysozyme stability comparison with the absence of the Mg(OH) 2 [114] .
In actual encapsulation processes, the suitable individual or combined strategies could be employed for improvement of protein stability. The maximum or full protein activity could be achieved by optimizing processing and operation parameters according to real systems.
METHODS FOR EVALUATION OF PROTEIN STABIL-ITY
Various techniques available for evaluation proteins stability are summarized in Table 4 . These techniques can be employed to detect the primary structure, secondary structure, tertiary structure, chemical stability and thermal stability of proteins.
The primary structure is usually measured by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) [73, 75, 78, 88] . The secondary structure could be assessed by Fourier transform infrared spectroscopy (FTIR) [78, 85, 87, 89] and circular dichroism [73, 75, 79, 87, 88, [122] [123] [124] . Fluorescence spectroscopy was usually employed to detect changes in tertiary structure of protein according to the emission (300-500 nm) from tryptophan and tyrosine residues in proteins under excitation wavelength of 280 nm [79, 85, 124] .
The chemical stability of proteins could be analyzed by using high performance liquid chromatography (HPLC) [73, 84, 86, 92, 99, 125] , high performance liquid chromatography-mass spectrometry (HPLC-MS) [99] , or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) [75] . Aggregation of proteins could be evaluated by using size exclusion chromatography (SEC) [75, 88, 92, [125] [126] [127] , capillary electrophoresis [128] , and western blotting [90, 112] .
Differential scanning calorimetry (DSC) is an ideal method to study protein thermal stability in solution, which is mainly used to measure the change of enthalpy ( H) and the midpoint temperature (T m ) of the denaturation for proteins [73, 88, 126] . The antigenicity activity of proteins could be determined by protein-specific enzyme-linked immunosorbent assay (ELISA) [73, 88, 127] .
The stability of some specific proteins can be measured according to their intrinsic characteristics. The stability of enzyme is usually determined by measuring their bioactivity. Several groups have evaluated the activity of lysozyme via enzymatic activity assay, by digesting bacterial cell walls of M. lysodeikticus with lysozyme and measuring the turbidity of the suspension [79, 83, 88] . Castellanos et al. detected the activity of -chymotrypsin and PEG--chymotrypsin using succinyl-Ala-Ala-Pro-Phe -p-nitroanilide as the substrate [82, 84] . Meng et al. determined the oxygen-loading activity of bovine hemoglobin to evaluate its molecular quaternary structure [10] . Pean et al. evaluated the stability of nerve growth factor (NGF) by measurement of bioactive NGF using a PC 12 cellbased bioassay [129] . 
Specific techniques
Enzymatic activity assay Bioactivity [79, [82] [83] [84] 88] Oxygen-loading activity Quaternary structure of BHb [10] PC 12 cell-based bioassay Bioactivity of NGF [129] In vivo biological analysis Bioactivity of insulin and rhEPO [7575, 112] Abbreviations: SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; CD, circular dichroism; FTIR, Fourier transform infrared spectroscopy; HPLC, high performance liquid chromatography; PHLC-MS, high performance liquid chromatography-mass spectrometry; MALDI-TOF MS, matrix-assisted laser desorption/ionization time-offlight mass spectrometry; SEC, size exclusion chromatography; CE, capillary electrophoresis; WB, western blotting; DSC, differential scanning calorimetry; ELISA, enzyme-linked immunosorbent assay; BHb, bovine hemoglobin; NGF, nerve growth factor; rhEPO, recombinant human erythropoitin.
The bioactivity of some proteins could be evaluated using in vivo biological analysis. For example, Manoharan et al. studied the bioactivity of insulin from microspheres in male Sprague-Dawley rats. The microspheres containing insulin were subcutaneously injected at neck region of diabetic rats, and then blood glucose concentrations and serum insulin concentrations were determined using glucose kits and the radioimmunoassay kits [75] . He et al. determined the biological activity of recombinant human erythropoietin (rhEPO) by detecting the number of reticulocytes in blood from BALB/c mice after subcutaneous administration of a single dose of rhEPO. The activity of rhEPO could be calculated according to the correlation between reticulocyte percentage and the rhEPO activity [112] .
CONCLUSION
As therapeutic proteins delivery systems, it is necessary to maintain protein bioactivity during microspheres or microcapsules formation as much as possible. Process operating conditions as well as the various surfaces that come in contact with proteins can have a direct or indirect influence on their integrity. Until now, the production of hydrophilic polymer microspheres and hydrophobic polymer microcapsules containing stable therapeutic proteins still remains a major challenge. To enable protein stabilization, the optimization of processing and formulation parameters is necessary. At present, many imaginative strategies for improving proteins stability during microspheres and microcapsules formation are being investigated. The use of specific additives for hydrophilic microspheres or stabilizers for hydrophobic microcapsules is the widely used to counter the denaturing factors. The stability of encapsulated proteins could also be improved by modification of proteins and polymers. Furthermore, the modification of preparation processes is another effective strategy. In the actual encapsulation process, the maximum or full protein stability retention within the microspheres or microcapsules might be achieved by individual or combined optimized strategies.
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